Notices. Notice of registration
332 words·~2 min read·
/register/2018/04/11/2018-07444·A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
BILLING CODE 4410-09-P DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA-392] Importer of Controlled Substances Registration ACTION: Notice of registration. SUMMARY: Registrants listed below have applied for and been granted registration by the Drug Enforcement Administration
(DEA)as importers of various classes of schedule I or II controlled substances. SUPPLEMENTARY INFORMATION: The companies listed below applied to be registered as importers of various basic classes of controlled substances. Information on previously published notices is listed in the table below. No comments or objections were submitted and no requests for hearing were submitted for these notices. Company FR docket Published Sharp (Bethlehem), LLC 83 FR 539 January 4, 2018. Catalent Pharma Solutions, LLC 83 FR 2215 January 16, 2018. Janssen Pharmaceuticals, Inc 83 FR 2214 January 16, 2018. Mylan Pharmaceuticals, Inc 83 FR 5809 February 9, 2018. Meridian Medical Technologies, Inc 83 FR 5810 February 9, 2018. Noramco, Inc 83 FR 5810 February 9, 2018. Johnson Matthey, Inc 83 FR 5811 February 9, 2018. Mylan Technologies, Inc 83 FR 5811 February 9, 2018. Mylan Pharmaceuticals, Inc 83 FR 8107 February 23, 2018. The Drug Enforcement Administration
(DEA)has considered the factors in 21 U.S.C. 823, 952(a) and 958(a) and determined that the registration of the listed registrants to import the applicable basic classes of schedule I or II controlled substances is consistent with the public interest and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971. The DEA investigated each company's maintenance of effective controls against diversion by inspecting and testing each company's physical security systems, verifying each company's compliance with state and local laws, and reviewing each company's background and history. Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in accordance with 21 CFR 1301.34, the DEA has granted a registration as an importer for schedule I or II controlled substances to the above listed companies. Dated: April 4, 2018. Susan A. Gibson, Deputy Assistant Administrator. [FR Doc. 2018-07444 Filed 4-10-18; 8:45 am]
Connectionstraces to 3
Citation graph
cites case law
Cites 3Cited by 0 across 0 sources